Showing results (271-280 of 373) with videos related to
Sort By:
Pageof 38
Annals of Surgical Oncology|May 17, 2020
What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?Patrick B Schwartz, Christopher C Stahl, Kara A Vande Walle, et al.Journal of Surgical Oncology|January 8, 2020
Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortiumKota Sahara, Diamantis I Tsilimigras, Shishir K Maithel, et al.Journal of Open Source Software|July 15, 2026
Bam-readcount - rapid generation of basepair-resolution sequence metricsAjay Khanna, David E Larson, Sridhar Nonavinkere Srivatsan, et al.JAMA Network Open|September 28, 2023
Venous Thromboembolism Chemoprophylaxis Adherence Rates After Major Cancer SurgeryCharles D Logan, Matthew T Hudnall, Cary Jo R Schlick, et al.Annals of Surgical Oncology|February 15, 2013
Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysisChing-Wei D Tzeng, Daniel E Abbott, Scott B Cantor, et al.Journal of Surgical Oncology|July 31, 2024
Understanding futility in pancreaticoduodenectomy: Insights from a national cohortClayton T Marcinak, Kaleem S Ahmed, Noelle K LoConte, et al.Clinical Breast Cancer|April 5, 2018
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive PhenotypeJeremy Force, Lynn J Howie, Sara E Abbott, et al.The Journal of Surgical Research|May 7, 2022
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?Eliza W Beal, J C Chen, Alex Kim, et al.Journal of the American College of Surgeons|January 16, 2017
Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional StudyGregory C Wilson, Shishir K Maithel, David Bentrem, et al.Annals of Surgical Oncology|July 28, 2016
Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First ApproachBrent T Xia, David A Habib, Vikrom K Dhar, et al.Pageof 38